NCT05871957 is a clinical trial of Vitamin D Drops in Hashimoto Thyroiditis, sponsored by Qianfoshan Hospital.

Who is sponsoring NCT05871957?

NCT05871957 is sponsored by Qianfoshan Hospital.

What drugs are being tested in NCT05871957?

Interventions in NCT05871957: Vitamin D Drops.

What condition does NCT05871957 study?

NCT05871957 studies Hashimoto Thyroiditis.

Is NCT05871957 still recruiting?

NCT05871957 is currently status unknown. Last updated 23 May 2023.

Last reviewed 2023-05-23 · How we verify

NCT05871957

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adjuvant Therapeutic Effect of Vitamin D on Hashimoto's Thyroiditis

Status unknown Last updated 23 May 2023

What this trial tests

trial testing Vitamin D Drops in Hashimoto Thyroiditis in 30 participants. Status unknown.

Timeline

1 June 2023

Primary endpoint
31 August 2023

30 September 2023

Quick facts

Lead sponsor	Qianfoshan Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 June 2023
Primary completion	31 August 2023
Estimated completion	30 September 2023

Drugs / interventions tested

Vitamin D Drops

Conditions studied

Hashimoto Thyroiditis — all drugs for Hashimoto Thyroiditis →

Sponsor

Qianfoshan Hospital

Who can join

Adults 18 to 60, female only, with Hashimoto Thyroiditis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to explore the relationship between vitamin D and Hashimoto's thyroiditis and to explore whether vitamin D can play an adjuvant role in the treatment of Hashimoto's thyroiditis. Epidemiological surveys show that vitamin D deficiency rates are as high as 50%-90% in HT patients. Dietary supplementation with vitamin D has been evaluated as a way to protect the thyroid gland from autoimmune damage, but the results of randomized clinical trials are unclear.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Qianfoshan Hospital trials

Trials by the same sponsor.

NCT05727618 — The Effect of Pituitrin on the Patients With Pulmonary Hypertension Undergoing Cardiac Surgery · NA · suspended
NCT06837831 — Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin · NA · recruiting
NCT07260760 — Clinical Comprehensive Evaluation of Neuroprotective Drugs for Acute Ischemic Stroke · not yet recruiting
NCT07362667 — A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA · recruiting
NCT07271849 — Nalbuphine Timing Effects on Hemodynamics and Analgesia in Elderly Patients · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05871957 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Qianfoshan Hospital
Last refreshed: 23 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05871957.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing